ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

Trials Approved by NCI CTEP For the Month of May

May 25, 2012